Martha Chekenya

7PUBLICATIONS
6CO-AUTHORS
Computational physiologyPredictive and prognostic markersGene and molecular therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 08, 2023
Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI.

Marianne H Hannisdal, Dorota Goplen, Saruar Alam

|Feb 02, 2023
Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions.

Hanne Blakstad, Jorunn Brekke, Mohummad Aminur Rahman

|Oct 13, 2021
Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy.

Victoria Smith Arnesen, Andrea Gras Navarro, Martha Chekenya

|Jun 25, 2020
Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.

Mohummad A Rahman, Jorunn Brekke, Victoria Arnesen

|Jul 20, 2019
Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival.

Andrea Gras Navarro, Heidi Espedal, Justin Vareecal Joseph

|Nov 09, 2014
NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.

Andrea Gras Navarro, Justyna Kmiecik, Lina Leiss

Pageof 2

Frequent Collaborators

2 joint publications

Mohummad Aminur Rahman

1 joint publications

Laura Trachsel-Moncho

1 joint publications

Anne Simonsen

1 joint publications

Victoria Smith Arnesen